CBD Medicine May Help Ease Another Form of Seizure

SATURDAY, Dec. 7, 2019 -- Prescription-grade CBD may help control hard-to-treat seizures caused by a rare genetic disorder, a preliminary study suggests.

The study involved 224 patients with tuberous sclerosis complex (TSC) -- a genetic condition that affects about one in 6,000 people, according to the U.S. National Institutes of Health. It causes noncancerous tumors to arise throughout the body, and -- in 90% of patients -- seizures that are often resistant to standard drugs.

Virtual Doc Visits Suffice for Many With Neurological Disorders

FRIDAY, Dec. 6, 2019 -- If you have a neurological disorder, a video chat with your doctor might be as good as an office visit for checking on your condition.

That's the conclusion of researchers who analyzed 101 studies on telemedicine use for concussion, traumatic brain injury, dementia, epilepsy, headache, multiple sclerosis, movement disorders, neuromuscular conditions and general neurology.

Sometimes, Aspirin May Be Enough to Ease Migraines

TUESDAY, Dec. 10, 2019 -- A cheap, century-old drug in most Americans' medicine cabinets -- aspirin -- may come to the rescue for people suffering from migraines, a new study finds.

While there are effective prescription medications, many migraine patients in the United States don't have access to them due to limited access to doctors or good insurance, or high insurance co-pays, said researchers at Florida Atlantic University, in Boca Raton.

Ultrasound May Ease Common Form of Hand Tremor

WEDNESDAY, Nov. 20, 2019 -- A treatment that delivers ultrasound waves to the brain may bring lasting relief to some people with debilitating hand tremors, a new study finds.

The study involved 76 patients with essential tremor -- a neurological condition that most often causes trembling in the hands during routine tasks like writing, eating and dressing. It can also affect the legs, head, trunk or voice.

New Type of Drug Might Ease Migraines

TUESDAY, Nov. 19, 2019 -- Migraine sufferers who cannot get relief from existing medications may soon have a novel treatment option, a new trial suggests.

The study, of nearly 1,700 patients, found that a pill called ubrogepant worked better than a placebo pill at halting migraines in progress.